MiMedx Group, Inc. (OTCBB:MDXG) is currently developing biomaterial-based products for use in the musculoskeletal specialties.
We believe biomaterials are capable of addressing a broad range of acute and chronic diseases and disorders, so we are developing a product portfolio consisting of competitive and unique solutions for surgeons and their patients. The Company presently has two subsidiaries, with operations in Tampa, Florida, and Marietta, Georgia.
Our product pipeline is focused on high-growth market segments that address large, unmet needs.
We plan to utilize our experienced management team to commercialize these medical technologies by advancing them through the proper regulatory approval processes, arranging for reliable and cost-effective manufacturing, and delivering these products to markets in Europe, the United States, and Asia.